Wednesday, August 1, 2012

Quantify Vendor Performance and Enhance Your Oversight Techniques at CBE 2012

Effectively managing the trial progress, vendor relationships and related costs requires attention to both qualitative and quantitative performance indicators. As a Clinical Outsourcing professional, assessing the performance of your clinical trial partners can mean the difference between a smooth trial process and thousands, if not millions, of dollars wasted.

The 6th Annual Strategic Clinical Outsourcing Event will equip you with the tools to:
  • - Launch a fully operational system to establish useful benchmarks and help CROs and sponsors find better matches
  • - Evaluate the role that sponsors play in contributing to their CRO’s performance
  • - Demonstrate how selected, study-specific questions can facilitate the assessment of CRO performance
  • - Assess the ROI and quantify the cost of preferred provider relationships
Featured Speakers:
  • - Scott Sawicki, Director, Clinical Contracting, Novartis
  • - Norman Mustafa, Global Head, Scientific Outsourcing, GlaxoSmithKline
  • - Craig A. Coffman, Sr. Director, Business Operations& Outsourcing, Endo Pharmaceuticals
  • - Adam Sabouni, PhD, Chief Development Officer, VP R&D, Regulatory Affairs, Novan Therapeutics
For more information on these sessions and the rest of the agenda, download the agenda.

Plus, this year’s program takes place as part of the 2nd Annual Clinical Business Expo – offering unmatched networking and learning opportunities among 600+ experts across the entire clinical operations spectrum!

Strategic Clinical Outsourcing and the Clinical Business Expo will take place September 19-20, 2012 with a pre-conference day September 18. As a reader of this blog, when you register to join us today and mention code XP1725BLOG, you’ll save 15% off the standard rate! If you have any questions, feel free to contact Jennifer Pereira.




No comments: